Innoviva, Inc.
US ˙ NasdaqGS ˙ US45781M1018

SecurityINVA / Innoviva, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership31,732 shares
Latest Disclosed Value $ 739,355
Citigroup Inc ownership in INVA / Innoviva, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 31,732 shares of Innoviva, Inc. (US:INVA) valued at $739,356 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 53,512 shares of Innoviva, Inc.. This represents a change in shares of -40.70% during the quarter. The current value of the position is $688,584 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (INVA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

INVA / Innoviva, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F INNOVIVA COM 45781M101 31,732 -21,780 -40.70 739 -30.87 0.0002
2026-02-13 2025-12-31 13F INNOVIVA COM 45781M101 53,512 -15,570 -22.54 1,070 -15.16 0.0005
2025-11-10 2025-09-30 13F INNOVIVA COM 45781M101 69,082 -173 -0.25 1,261 -9.42 0.0006
2025-08-11 2025-06-30 13F INNOVIVA COM 45781M101 69,255 -81,717 -54.13 1,391 -49.18 0.0007
2025-05-12 2025-03-31 13F INNOVIVA COM 45781M101 150,972 5,285 3.63 2,737 8.31 0.0014
2025-02-12 2024-12-31 13F INNOVIVA COM 45781M101 145,687 60,857 71.74 2,528 54.27 0.0015
2024-11-12 2024-09-30 13F INNOVIVA COM 45781M101 84,830 25,546 43.09 1,638 68.52 0.0009
2024-08-12 2024-06-30 13F INNOVIVA COM 45781M101 59,284 1,581 2.74 972 10.58 0.0006
2024-05-10 2024-03-31 13F INNOVIVA COM 45781M101 57,703 54,827 1,906.36 879 7,890.91 0.0006
2024-02-09 2023-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 2,876 2,861 19,073.33 12 0.0000
2024-02-09 2023-12-31 13F INNOVIVA COM 45781M101 54,031 21,042 867 0.0003
2023-12-06 2023-09-30 13F/A-1 THESEUS PHARMACEUTICALS COM 88369M101 15 -6,014 -99.75 0 -100.00 0.0000
2023-12-06 2023-09-30 13F/A-1 INNOVIVA COM 45781M101 32,989 -115,546 429 0.0003
2023-11-09 2023-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 15 -6,014 0 0.0000
2023-11-09 2023-09-30 13F INNOVIVA COM 45781M101 32,989 -115,546 429 0.0001
2023-08-10 2023-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 6,029 -52,093 -89.63 56 -91.42 0.0000
2023-08-10 2023-06-30 13F INNOVIVA COM 45781M101 148,535 90,413 1,891 0.0012
2023-05-11 2023-03-31 13F INNOVIVA COM 45781M101 58,122 58,007 50,440.87 654 -1.95 0.0005
2023-02-09 2022-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 115 -142 -55.25 1 -100.00 0.0000
2023-02-09 2022-12-31 13F INNOVIVA COM 45781M101 50,311 -2,136 667 0.0005
2022-11-10 2022-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 257 -916 -78.09 1 -83.33 0.0000
2022-11-10 2022-09-30 13F INNOVIVA COM 45781M101 52,447 -4,383 609 0.0004
2022-08-10 2022-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 1,173 724 161.25 6 20.00 0.0000
2022-08-10 2022-06-30 13F INNOVIVA COM 45781M101 56,830 -11,172 839 0.0006
2022-05-12 2022-03-31 13F THESEUS PHARMACEUTICALS COM 88369M101 449 -2,698 -85.73 5 -87.50 0.0000
2022-05-12 2022-03-31 13F INNOVIVA COM 45781M101 68,002 7,294 1,316 0.0008
2022-02-10 2021-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 3,147 -55,414 -94.63 40 -95.91 0.0000
2022-02-10 2021-12-31 13F INNOVIVA COM 45781M101 60,708 2,147 1,047 0.0006
2021-11-10 2021-09-30 13F INNOVIVA COM 45781M101 58,561 14,708 33.54 979 66.21 0.0006
2021-08-10 2021-06-30 13F INNOVIVA COM 45781M101 43,853 30,782 235.50 589 277.56 0.0004
2021-05-13 2021-03-31 13F INNOVIVA COM 45781M101 13,071 -49,230 -79.02 156 -79.77 0.0001
2021-02-11 2020-12-31 13F INNOVIVA COM 45781M101 62,301 -18,179 -22.59 771 -8.32 0.0005
2020-11-12 2020-09-30 13F INNOVIVA COM 45781M101 80,480 -41,595 -34.07 841 -50.70 0.0005
2020-08-12 2020-06-30 13F INNOVIVA COM 45781M101 122,075 28,467 30.41 1,706 54.95 0.0013
2020-05-12 2020-03-31 13F INNOVIVA COM 45781M101 93,608 -60,103 -39.10 1,101 -49.40 0.0010
2020-02-12 2019-12-31 13F INNOVIVA COM 45781M101 153,711 68,880 81.20 2,176 143.40 0.0016
2019-11-08 2019-09-30 13F INNOVIVA COM 45781M101 84,831 66,208 355.52 894 228.68 0.0007
2019-08-12 2019-06-30 13F INNOVIVA COM 45781M101 18,623 7,460 66.83 272 73.25 0.0002
2019-05-13 2019-03-31 13F INNOVIVA COM 45781M101 11,163 -151,292 -93.13 157 -94.46 0.0002
2019-02-12 2018-12-31 13F INNOVIVA COM 45781M101 162,455 70,937 77.51 2,834 103.15 0.0029
2018-11-13 2018-09-30 13F INNOVIVA COM 45781M101 91,518 -56,985 -38.37 1,395 -31.95 0.0012
2018-08-10 2018-06-30 13F INNOVIVA COM 45781M101 148,503 144,240 3,383.53 2,050 2,787.32 0.0019
2018-05-11 2018-03-31 13F INNOVIVA COM 45781M101 4,263 -29,544 -87.39 71 -85.21 0.0001
2018-02-12 2017-12-31 13F INNOVIVA COM 45781M101 33,807 -40,128 -54.27 480 -54.02 0.0004
2017-11-13 2017-09-30 13F INNOVIVA COM 45781M101 73,935 -45,289 -37.99 1,044 -31.59 0.0009
2017-08-11 2017-06-30 13F INNOVIVA COM 45781M101 119,224 15,900 15.39 1,526 6.79 0.0014
2017-05-12 2017-03-31 13F INNOVIVA COM 45781M101 103,324 -51,136 -33.11 1,429 -13.50 0.0013
2017-02-10 2016-12-31 13F INNOVIVA COM 45781M101 154,460 118,091 324.70 1,652 313.00 0.0015
2016-11-10 2016-09-30 13F INNOVIVA COM 45781M101 36,369 9,653 36.13 400 42.35 0.0004
2016-08-12 2016-06-30 13F INNOVIVA COM 45781M101 26,716 -60,251 -69.28 281 -74.34 0.0003
2016-05-13 2016-03-31 13F INNOVIVA COM 45781M101 86,967 49,237 130.50 1,095 175.13 0.0012
2016-02-12 2015-12-31 13F THERAVANCE COM 88338T104 37,730 -9,885 -20.76 398 16.37 0.0004
2015-11-13 2015-09-30 13F THERAVANCE COM 88338T104 47,615 45,882 2,647.55 342 1,003.23 0.0003
2015-08-13 2015-06-30 13F THERAVANCE COM 88338T104 1,733 -19,593 -91.87 31 -90.75 0.0000
2015-05-14 2015-03-31 13F THERAVANCE COM 88338T104 21,326 -18,978 -47.09 335 -41.23 0.0003
2015-02-17 2014-12-31 13F THERAVANCE COM 88338T104 40,304 37,432 1,303.34 570 1,063.27 0.0005
2014-11-14 2014-09-30 13F THERAVANCE COM 88338T104 2,872 746 35.09 49 -22.22 0.0000
2014-08-14 2014-06-30 13F THERAVANCE COM 88338T104 2,126 -33,109 -93.97 63 -94.23 0.0001
2014-05-15 2014-03-31 13F THERAVANCE COM 88338T104 35,235 -3,854 -9.86 1,091 -21.68 0.0011
2014-02-14 2013-12-31 13F THERAVANCE COM 88338T104 39,089 16,516 73.17 1,393 50.92 0.0013
2013-11-14 2013-09-30 13F THERAVANCE COM 88338T104 22,573 20,896 1,246.03 923 1,342.19 0.0009
2013-08-14 2013-06-30 13F THERAVANCE COM 88338T104 1,677 1,677 64 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-02-12 2018-12-31 13F INNOVIVA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-13 2018-09-30 13F INNOVIVA COM Call 7,200 3,500.00 110 3,566.67 n/a n/a n/a
2018-08-10 2018-06-30 13F INNOVIVA COM Call 200 -75.00 3 -76.92 n/a n/a n/a
2018-05-11 2018-03-31 13F INNOVIVA COM Call 800 -74.19 13 -70.45 n/a n/a n/a
2018-02-12 2017-12-31 13F INNOVIVA COM Call 3,100 933.33 44 1,000.00 n/a n/a n/a
2017-11-13 2017-09-30 13F INNOVIVA COM Call 300 50.00 4 33.33 n/a n/a n/a
2017-08-11 2017-06-30 13F INNOVIVA COM Call 200 -89.47 3 -88.46 n/a n/a n/a
2017-05-12 2017-03-31 13F INNOVIVA COM Call 1,900 -17.39 26 4.00 n/a n/a n/a
2017-02-10 2016-12-31 13F INNOVIVA COM Call 2,300 9.52 25 8.70 n/a n/a n/a
2016-11-10 2016-09-30 13F INNOVIVA COM Call 2,100 -16.00 23 -11.54 n/a n/a n/a
2016-08-12 2016-06-30 13F INNOVIVA COM Call 2,500 -51.92 26 -60.00 n/a n/a n/a
2016-05-13 2016-03-31 13F INNOVIVA COM Call 5,200 2,500.00 65 3,150.00 n/a n/a n/a
2016-02-12 2015-12-31 13F THERAVANCE COM Call 200 -94.29 2 -92.00 n/a n/a n/a
2015-11-13 2015-09-30 13F THERAVANCE COM Call 3,500 -47.76 25 -79.34 n/a n/a n/a
2015-08-13 2015-06-30 13F THERAVANCE COM Call 6,700 121 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-05-13 2019-03-31 13F INNOVIVA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-12 2018-12-31 13F INNOVIVA COM Put 13,900 -16.27 243 -3.95 n/a n/a n/a
2018-11-13 2018-09-30 13F INNOVIVA COM Put 16,600 13.70 253 25.87 n/a n/a n/a
2018-08-10 2018-06-30 13F INNOVIVA COM Put 14,600 5.04 201 -13.36 n/a n/a n/a
2018-05-11 2018-03-31 13F INNOVIVA COM Put 13,900 -34.12 232 -22.41 n/a n/a n/a
2018-02-12 2017-12-31 13F INNOVIVA COM Put 21,100 299 n/a n/a n/a
2017-11-13 2017-09-30 13F INNOVIVA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-08-11 2017-06-30 13F INNOVIVA COM Put 3,000 -41.18 38 -46.48 n/a n/a n/a
2017-05-12 2017-03-31 13F INNOVIVA COM Put 5,100 142.86 71 222.73 n/a n/a n/a
2017-02-10 2016-12-31 13F INNOVIVA COM Put 2,100 -16.00 22 -18.52 n/a n/a n/a
2016-11-10 2016-09-30 13F INNOVIVA COM Put 2,500 27 n/a n/a n/a
2016-08-12 2016-06-30 13F INNOVIVA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-13 2016-03-31 13F INNOVIVA COM Put 200 -60.00 3 -40.00 n/a n/a n/a
2016-02-12 2015-12-31 13F THERAVANCE COM Put 500 -37.50 5 -16.67 n/a n/a n/a
2015-11-13 2015-09-30 13F THERAVANCE COM Put 800 -27.27 6 -70.00 n/a n/a n/a
2015-08-13 2015-06-30 13F THERAVANCE COM Put 1,100 20 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.